EWS CAR-T, though displaying enhanced cytotoxicity in vitro (Fig. 2d and Extended Data Fig. 2b,e) and better tumor control at early time points in vivo (day 7; Fig. 2l), did not achieve a sustained antitumor effect (Fig. 2l). Here, EWSR1 is linked to neoplasm.